Smith L. Mary Insider Trades

Insider Trading History

Track insider trading activity for Smith L. Mary. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
SpringWorks Therapeutics
SpringWorks Therapeutics SWTX
Chief Development Officer
Holding Value $11M 233,363 shares
Last Trade
Jan 08, 2024 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$147k 3,535 shares
$41.53
$46.99
SpringWorks Therapeutics
SpringWorks Therapeutics SWTX
Chief Development Officer
Holding Value $11.1M 236,898 shares
Last Trade
Jan 05, 2024 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$83.4k 2,197 shares
$37.96
$46.99
SpringWorks Therapeutics
SpringWorks Therapeutics SWTX
Chief Development Officer
Holding Value $11.2M 239,095 shares
Last Trade
Jan 04, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.3M 60,000 shares
$38.40
$46.99
SpringWorks Therapeutics
SpringWorks Therapeutics SWTX
Chief Development Officer
Holding Value $10.2M 217,939 shares
Last Trade
Jun 30, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$150k 5,720 shares
$26.22
$46.99
SpringWorks Therapeutics
SpringWorks Therapeutics SWTX
Chief Development Officer
Holding Value $9.97M 212,219 shares
Last Trade
Jan 07, 2023 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$28.2k 1,068 shares
$26.41
$46.99
SpringWorks Therapeutics
SpringWorks Therapeutics SWTX
Chief Development Officer
Holding Value $10M 213,287 shares
Last Trade
Jan 06, 2023 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$67.5k 2,452 shares
$27.52
$46.99
SpringWorks Therapeutics
SpringWorks Therapeutics SWTX
Chief Development Officer
Holding Value $9.07M 193,076 shares
Last Trade
Jul 18, 2022 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$44.2k 1,551 shares
$28.47
$46.99
SpringWorks Therapeutics
SpringWorks Therapeutics SWTX
Chief Development Officer
Holding Value $9.15M 194,627 shares
Last Trade
Jun 30, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$150k 6,092 shares
$24.62
$46.99
SpringWorks Therapeutics
SpringWorks Therapeutics SWTX
Chief Development Officer
Holding Value $8.86M 188,535 shares
Last Trade
Jan 07, 2022 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$66.2k 1,181 shares
$56.06
$46.99
SpringWorks Therapeutics
SpringWorks Therapeutics SWTX
Chief Development Officer
Holding Value $8.83M 187,944 shares
Last Trade
Jan 07, 2022 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$99.3k 1,772 shares
$56.06
$46.99
SpringWorks Therapeutics
SpringWorks Therapeutics SWTX
Chief Development Officer
Holding Value $8.91M 189,716 shares
Last Trade
Jan 06, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$4.12M 69,207 shares
$59.46
$46.99
SpringWorks Therapeutics
SpringWorks Therapeutics SWTX
Chief Development Officer
Holding Value $3.96M 84,296 shares
Last Trade
Oct 13, 2021 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$562k 10,000 shares
$56.22
$46.99
SpringWorks Therapeutics
SpringWorks Therapeutics SWTX
Chief Development Officer
Holding Value $8.34M 177,511 shares
Last Trade
Oct 13, 2021 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$562k 10,000 shares
$56.22
$46.99
SpringWorks Therapeutics
SpringWorks Therapeutics SWTX
Chief Development Officer
Holding Value $7.87M 167,511 shares
Last Trade
Oct 13, 2021 Sale (Open Market)Shares sold on the open market or in a private sale.
$560k 10,000 shares
$55.97
$46.99
SpringWorks Therapeutics
SpringWorks Therapeutics SWTX
Chief Development Officer
Holding Value $8.34M 177,511 shares
Last Trade
Jul 13, 2021 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$809k 10,000 shares
$80.93
$46.99
SpringWorks Therapeutics
SpringWorks Therapeutics SWTX
Chief Development Officer
Holding Value $7.87M 167,511 shares
Last Trade
Jul 13, 2021 Sale (Open Market)Shares sold on the open market or in a private sale.
$809k 10,000 shares
$80.88
$46.99
SpringWorks Therapeutics
SpringWorks Therapeutics SWTX
Chief Development Officer
Holding Value $4.43M 94,296 shares
Last Trade
Jul 13, 2021 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$809k 10,000 shares
$80.93
$46.99
SpringWorks Therapeutics
SpringWorks Therapeutics SWTX
Chief Development Officer
Holding Value $8.34M 177,511 shares
Last Trade
Apr 13, 2021 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$694k 10,000 shares
$69.41
$46.99
SpringWorks Therapeutics
SpringWorks Therapeutics SWTX
Chief Development Officer
Holding Value $7.87M 167,511 shares
Last Trade
Apr 13, 2021 Sale (Open Market)Shares sold on the open market or in a private sale.
$681k 10,000 shares
$68.07
$46.99
SpringWorks Therapeutics
SpringWorks Therapeutics SWTX
Chief Development Officer
Holding Value $4.9M 104,296 shares
Last Trade
Apr 13, 2021 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$694k 10,000 shares
$69.41
$46.99

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up